Biodexa Pharmaceuticals Plc Share Price

NASDAQ: BDRX

Small Cap

$6.05

+0.03

(+0.50%)

Live

as on September 15, 2025 at 10:11 pm IST

$₹

Biodexa Pharmaceuticals Plc Stock Performance

as on September 15, 2025 at 10:11 pm IST

Day's Low
Day's High
$5.99
Day's Price Range
$6.47
$6.05
0.99%
Downside
6.94%
Upside
52 Week's Low
52 Week's High
$5
52-Week Price Range
$108.9
$6.05
17.35%
Downside
1700.00%
Upside

Biodexa Pharmaceuticals Plc share price movements today

Previous Close: $6.02
Open: $5.99
Volume: 272.1K
Day's Low - High: $5.99 - $6.47
52 Week Low - High: $5 - $108.9

Biodexa Pharmaceuticals Plc Historical Returns

1 Month Return: -15.77 %
3 Month Return: -44.58 %
1 Year Return: -94.24 %
3 Year Return: 0 %
5 Year Return: 0 %

Biodexa Pharmaceuticals Plc Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceuticals Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-0.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-9.1M

Revenue (TTM)

83.0K

Profit Margin

0.00%

Return On Equity TTM

4833300.00%

Biodexa Pharmaceuticals Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceuticals Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biodexa Pharmaceuticals Plc	BUY	$3.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Biodexa Pharmaceuticals Plc Stock including INR - Dollar returns

The Biodexa Pharmaceuticals Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biodexa Pharmaceuticals Plc investment value today

Current value as on today

₹10,859

Returns

₹89,141

(-89.14%)

Returns from Biodexa Pharmaceuticals Plc Stock

₹94,126 (-94.13%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Biodexa Pharmaceuticals Plc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceuticals Plc. Average target price of $183.98

Biodexa Pharmaceuticals Plc Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceuticals Plc.

What analysts predicted

96.71%UPSIDE

Target Price

$183.98

Current Price

$6.05

Analyzed by

7 Analysts

Target

$183.98

Biodexa Pharmaceuticals Plc target price $183.98, a slight upside of 96.71% compared to current price of $6.05. According to 7 analysts rating.

Biodexa Pharmaceuticals Plc Stock's Interest Amongst Investors

Search interest for Biodexa Pharmaceuticals Plc Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-8% versus previous 30 day period

Biodexa Pharmaceuticals Plc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Total Revenue	0	0	0	0	0	0	0
Gross Profit	-1	-1	-3	-1	-2	-1	-2
Operating Income	-3	-1	-3	-2	-4	-1	-3
EBITDA	-3	-1	-3	-2	-4	-1	-2
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-3	-2	-5	-1	-3	-1	-3
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-3	-2	-5	-2	-4	-1	-3
Net Profit Margin	-654.06%	-1989.18%	-1989.18%	-1197.32%	-1197.32%	-4230.12%	-4230.12%

Biodexa Pharmaceuticals Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	1	0	1	0	0	0	0	0	-
Gross Profit	1	-6	-7	-7	-9	-7	-5	-5	-4	-6
Operating Income	-10	-9	-11	-11	-11	-10	-6	-8	-8	-9
EBITDA	-10	-5	-10	-10	-9	-22	-5	-7	-7	-9
Interest Expense	-	-	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	1	1	0	0	0	0
Income Before Tax	-11	-8	-12	-12	-10	-23	-6	-8	-7	-5
Income Tax Expense	1	2	1	2	1	1	0	0	0	0
Net Income	-10	-6	-11	-10	-11	-29	-7	-9	-8	-7
Net Profit Margin	-734.47%	-465.68%	-1183.52%	-534.98%	-1355.79%	-6469.10%	-944.64%	-1095.28%	-1858.01%	0.00%

Biodexa Pharmaceuticals Plc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024
Net Income	-2	-4	-1	-3	-1	-3	-1	-3	-2
Operating Cash Flow	-1	-3	-1	-3	-1	-2	-2	-4	-7
Investing Cash Flow	0	0	0	0	-	0	-	0	0
Financing Cash Flow	0	0	3	6	1	3	2	4	3
Change in Cash	-6	-1	1	1	0	0	0	5	-5

Biodexa Pharmaceuticals Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-20	-16	-15	-10	-22	-5	-7	-7	-5
Operating Cash Flow	-13	-12	-13	-6	-9	-6	-7	-6	-12
Investing Cash Flow	-1	-1	9	-3	2	0	0	0	0
Financing Cash Flow	15	10	-6	18	3	8	0	10	8
Change in Cash	1	-4	-10	8	-3	2	-7	3	-4

Insights on Biodexa Pharmaceuticals Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, BDRX stock has moved up by 13.2%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.30M → -2.42M (in $), with an average increase of 36.6% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 169.8%

About Biodexa Pharmaceuticals Plc

midatech is a world leader in the design, synthesis and manufacture of biocompatible gold nanoparticles (gnps) with a core focus on therapeutics for diabetes and cancer. midatech has a strong pipeline of product candidates in clinical and pre-clinical development for the treatment of diabetes and various cancers. in 2012, midatech established midasol therapeutics lp, a strategic joint venture with monosol rx llc to focus on the development and commercialization, via partnering or licensing, of products primarily for the treatment of diabetes. midasol’s lead product, midaform™ insulin pharmfilm, is a unique product for the oral delivery of insulin in diabetic patients and will enter phase ii clinical studies in 2014. these technologies are also being evaluated in the diabetes area by a major us pharmaceutical company. midatech’s unique gnp technology enables the administration and targeted delivery of therapeutic compounds to specific cells and tissues. multiple drug molecules can b

Organisation	Biodexa Pharmaceuticals Plc
Headquarters	1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
CEO	Mr. Stephen Anthony Stamp
E-voting on shares	Click here to vote

Key Management of Biodexa Pharmaceuticals Plc

Name	Title
Mr. Stephen Anthony Stamp	CEO, CFO, Company Secretary & Director
Dr. Daniel Palmer MBA, Ph.D.	Vice President of Technology
Mr. Steve Ellul	Chief Business Officer
Dr. Gary A. Shangold CPI, FACOG, M.D.	Chief Medical Officer
Noreen Bhatti	Vice President of Clinical Operations
Ms. Fiona Sharp	Group Financial Controller

FAQs

What is Biodexa Pharmaceuticals Plc share price today?

Biodexa Pharmaceuticals Plc share price today is $6.05 as on September 15, 2025 at 10:11 pm IST. Biodexa Pharmaceuticals Plc share today touched a day high of $6.47 and a low of $5.99.

What is the 52 week high and 52 week low for Biodexa Pharmaceuticals Plc share?

Biodexa Pharmaceuticals Plc share touched a 52 week high of $108.9 on October 16, 2024 and a 52 week low of $5 on September 8, 2025. Biodexa Pharmaceuticals Plc stock price today i.e. September 15, 2025 at 10:11 pm IST is trending at $6.05,which is 94.44% down from its 52 week high and 21.00% up from its 52 week low.

What is Biodexa Pharmaceuticals Plc's market capitalisation today?

Biodexa Pharmaceuticals Plc market capitalisation is $0.00T as on September 15, 2025 at 10:11 pm IST.

How to invest in Biodexa Pharmaceuticals Plc Stock (BDRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biodexa Pharmaceuticals Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceuticals Plc Shares that will get you 0.2479 shares as per Biodexa Pharmaceuticals Plc share price of $6.05 per share as on September 15, 2025 at 10:11 pm IST.

What is the minimum amount required to buy Biodexa Pharmaceuticals Plc Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceuticals Plc (BDRX) shares with as little as ₹88.141 or $1 (as of September 15, 2025 at 10:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Biodexa Pharmaceuticals Plc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 10:38 pm IST). Based on Biodexa Pharmaceuticals Plc share’s latest price of $6.05 as on September 15, 2025 at 10:11 pm IST, you will get 1.6529 shares of Biodexa Pharmaceuticals Plc. Learn more about fractional shares .